Individual differences in prefrontal cortical activation on the Tower of London planning task: implication for effortful processing

The European Journal of Neuroscience
F CazalisS Granon

Abstract

Solving challenging ('effortful') problems is known to involve the dorsal and dorsolateral prefrontal cortex in normal volunteers, although there is considerable individual variation. In this functional magnetic resonance imaging study, we show that healthy subjects with different levels of performance in the Tower of London planning task exhibit different patterns of brain activation. All subjects exhibited significant bilateral activation in the dorsolateral prefrontal cortex, the anterior and posterior cingulate areas and the parietal cortex. However, 'standard performers' (performance < 70% correct) and 'superior performers' (performance >70% correct) differed in the patterns of activation exhibited. Superior performers showed a significantly more spatially extended activation in the left dorsolateral prefrontal cortex than did standard performers, whereas the latter group tended to show increased activation of the anterior cingulate region.

References

Jan 1, 1990·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·T Ono, M Tachibana
Jun 25, 1982·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·T Shallice
Nov 16, 1995·Nature·M D'EspositoM Grossman
Dec 1, 1994·Journal of Clinical and Experimental Neuropsychology·R KrikorianN Gay
Apr 1, 1994·Current Opinion in Neurobiology·W SchneiderM Worden
Dec 15, 1995·Annals of the New York Academy of Sciences·P S Goldman-Rakic
Feb 1, 1996·The European Journal of Neuroscience·A M OwenA C Evans
Jun 1, 1996·Neuropsychologia·S C BakerT W Robbins
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·S Dehaene, J P Changeux
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·S E PetersenM E Raichle
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·S DehaeneJ P Changeux
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·B Rypma, M D'Esposito
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·C S CarterJ D Cohen
Feb 7, 2001·Current Opinion in Neurobiology·P A CarpenterE D Reichle
Oct 31, 2000·Journal of Cognitive Neuroscience·T L HodgsonC Kennard
Feb 13, 2001·Neuropsychologia·J B RoweR E Passingham
Apr 13, 2001·Current Opinion in Neurobiology·J Tanji, E Hoshi
Jul 13, 2001·Nature·N K LogothetisA Oeltermann
Oct 10, 2001·Current Biology : CB·L J Otten, M D Rugg
Jun 8, 2002·Stroke; a Journal of Cerebral Circulation·A FeydyM A Maier
Aug 9, 2002·Journal of Cognitive Neuroscience·Bart RypmaMark D'Esposito
Oct 9, 2002·Current Opinion in Neurobiology·Seong-Gi Kim, Seiji Ogawa

❮ Previous
Next ❯

Citations

Feb 15, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Guy G PotterK R Ranga Krishnan
Jun 7, 2006·Acta Paediatrica·Sylvie Granon, Jean-Pierre Changeux
Feb 9, 2010·Cerebral Cortex·Maki S KoyamaMichael P Milham
Jun 5, 2010·Cerebral Cortex·Christoph P KallerJosef M Unterrainer
Jun 28, 2011·Neuropsychobiology·A Del CasaleP Girardi
Jul 24, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sylvie GranonJean-Pierre Changeux
Nov 26, 2010·Cognitive, Affective & Behavioral Neuroscience·Kristien Aarts, Gilles Pourtois
Oct 25, 2006·Brain Injury : [BI]·Fabienne CazalisPhilippe Azouvi
Jan 29, 2005·Human Brain Mapping·Thomas R KnöscheAngela D Friederici
Jul 14, 2005·Journal of Intellectual Disability Research : JIDR·R M Walley, M D C Donaldson
Jun 6, 2009·Psychophysiology·Christoph P KallerJosef M Unterrainer
Sep 26, 2012·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Dorottya PapGabriella Juhasz
Oct 20, 2006·Brain and Cognition·Paula Adriana Rodrigues GouveiaOrlando Francisco Amodeo Bueno
Jun 30, 2006·Brain and Cognition·Carolyn H DeclerckBert De Brabander
Jun 27, 2006·Neuropsychologia·Miya R AsatoBeatriz Luna
Apr 28, 2006·Emotion·Alexander J ShackmanRichard J Davidson
Dec 17, 2014·Schizophrenia Research·Edith J LiemburgAndré Aleman
Oct 2, 2012·Neuropsychologia·Shannon M FosterDeana B Davalos
Apr 18, 2006·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Pedro Cabral
Jul 9, 2008·Journal of Clinical and Experimental Neuropsychology·J M UnterrainerB Rahm
Aug 8, 2019·JAMA Surgery·Hemel Narendra ModiDaniel Richard Leff
Apr 29, 2020·Journal of the International Neuropsychological Society : JINS·Yana PanikratovaRoza Vlasova
Nov 2, 2019·Cerebral Cortex·Finnegan J CalabroBeatriz Luna
Aug 5, 2020·Network : Computation in Neural Systems·Henry O C JordanSimon M Stringer
Feb 14, 2021·Brain Sciences·Vykinta ParciauskaiteInga Griskova-Bulanova
Feb 29, 2020·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Yana R PanikratovaEkaterina V Pechenkova
Apr 10, 2021·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Halle QuangFiona Kumfor
Jun 3, 2021·Journal of Personalized Medicine·Vykinta ParciauskaiteInga Griskova-Bulanova
Aug 14, 2021·Scientific Reports·David FramorandoAlan J Pegna
Sep 2, 2021·NeuroImage·Alexandra M CrossMarc F Joanisse

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.